ADAMIS PHARMACEUTICALS CORP (ADMP)       0.2201  -0.01 (-4.3%)

0.2201  -0.01 (-4.3%)

US00547W2089 - Common Stock - After market: 0.2252 +0.01 (+2.32%)

News Image
3 months ago - Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Management to host webcast/conference call today at 2:00 p.m. PT / 5:00 p.m. ...

News Image
3 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We're starting off the day with an overview of the biggest pre-market stock movers on Tuesday and the latest news this morning!

News Image
4 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Good morning, investor! We're starting off Thursday with a breakdown of the biggest pre-market stock movers this morning!

News Image
4 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

It's time for another dive into the biggest pre-market stock movers as we check out what's behind shares moving on Wednesday!

News Image
4 months ago - Adamis Pharmaceuticals Corporation

Adamis Announces Review of Strategic Alternatives

SAN DIEGO, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a specialty biopharmaceutical company primarily focused...

News Image
5 months ago - Market News Video

Wednesday Sector Laggards: Drugs, Airlines

News Image
5 months ago - Adamis Pharmaceuticals Corporation

Adamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk Subjects

Interim data from the Phase 2/3 clinical trial of Tempol did not demonstrate statistical significance of its primary endpoint of clinical resolution of...

News Image
5 months ago - Adamis Pharmaceuticals Corporation

Adamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol in COVID-19 Positive High-Risk Subjects

The clinical trial of Tempol has reached the initial planned enrollment of 248 subjects Independent Data Monitoring Board to review interim data from...

News Image
6 months ago - Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Announces Results of Annual Meeting of Stockholders

Meeting adjourned only with respect to reverse stock split proposal until September 8, 2022...

News Image
6 months ago - Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Management to host webcast/conference call today at 1:30 p.m. PT / 4:30 p.m. ...